Methods for Evaluation of Antivirals and Neutralizing Antibodies Against Tick-Borne Encephalitis Virus
- PMID: 40512316
- DOI: 10.1007/978-1-0716-4587-1_14
Methods for Evaluation of Antivirals and Neutralizing Antibodies Against Tick-Borne Encephalitis Virus
Abstract
Tick-borne encephalitis (TBE) is a potentially fatal neuroinfection of humans caused by the TBE virus. There is no specific therapy for TBE, as treatment is only supportive. Therefore, efforts to develop an effective specific therapy for TBE are warranted. Small molecule inhibitors and monoclonal antibodies are under intense investigation as potential therapeutics to combat TBE in humans. Here we describe the basic methods that can be used to test small molecule antivirals or monoclonal antibodies against TBEV. These include in vitro methods such as plaque assays, neutralizing assays, immunofluorescence staining of viral antigen, and cell-based antiviral assays, as well as in vivo assays in mouse model of TBE.
Keywords: Antivirals; Immunofluorescence; Monoclonal antibodies; Mouse infection; Neutralization test; Plaque assay; Tick-borne encephalitis virus.
© 2025. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Development of blood-brain barrier-penetrating antibodies for neutralizing tick-borne encephalitis virus in the brain.mSphere. 2025 Jul 29;10(7):e0018425. doi: 10.1128/msphere.00184-25. Epub 2025 Jul 7. mSphere. 2025. PMID: 40622136 Free PMC article.
-
Development and characterization of recombinant tick-borne encephalitis virus expressing mCherry reporter protein: A new tool for high-throughput screening of antiviral compounds, and neutralizing antibody assays.Antiviral Res. 2021 Jan;185:104968. doi: 10.1016/j.antiviral.2020.104968. Epub 2020 Nov 4. Antiviral Res. 2021. PMID: 33157129
-
Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines.Antiviral Res. 2019 Apr;164:23-51. doi: 10.1016/j.antiviral.2019.01.014. Epub 2019 Jan 31. Antiviral Res. 2019. PMID: 30710567 Review.
-
Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.J Med Virol. 1996 Jan;48(1):102-7. doi: 10.1002/(SICI)1096-9071(199601)48:1<102::AID-JMV16>3.0.CO;2-I. J Med Virol. 1996. PMID: 8825718
-
Alimentary Infections by Tick-Borne Encephalitis Virus.Viruses. 2021 Dec 30;14(1):56. doi: 10.3390/v14010056. Viruses. 2021. PMID: 35062261 Free PMC article. Review.
References
-
- Holding M et al (2019) Detection of new endemic focus of tick-borne encephalitis virus (TBEV), Hampshire/Dorset border, England. Euro Surveill 24(47):24 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources